Next Article in Journal / Special Issue
A New Practice to Monitor the Fabrication Process of Fab-Targeting Ligands from Bevacizumab by LC-MS: Preparation and Analytical Characterization
Previous Article in Journal
The Development and the Validation of a Novel Dissolution Method of Favipiravir Film-Coated Tablets
Previous Article in Special Issue
Using Metabolite Data to Develop Patient Centric Specification for Amide Impurity in Vildagliptin Tablets
 
 
Review

Article Versions Notes

Sci. Pharm. 2022, 90(1), 4; https://doi.org/10.3390/scipharm90010004
Action Date Notes Link
article xml file uploaded 27 December 2021 08:21 CET Original file -
article xml uploaded. 27 December 2021 08:21 CET Update https://www.mdpi.com/2218-0532/90/1/4/xml
article pdf uploaded. 27 December 2021 08:21 CET Version of Record https://www.mdpi.com/2218-0532/90/1/4/pdf
article html file updated 27 December 2021 08:22 CET Original file -
article html file updated 31 July 2022 00:37 CEST Update https://www.mdpi.com/2218-0532/90/1/4/html
Back to TopTop